Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelson L Michael

Showing results (71-80 of 387) with videos related to

Pageof 39
Sort By:
Virology|April 26, 2008
Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cellsGustavo H Kijak, Luiz Mario Janini, Sodsai Tovanabutra, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 28, 2002
Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5Tarek Elbeik, W Gregory Alvord, Rapee Trichavaroj, et al.
Virology|April 25, 2008
Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different modelsBruce K Brown, Lindsay Wieczorek, Eric Sanders-Buell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2011
Medical encounter characteristics of HIV seroconverters in the US Army and Air Force, 2000–2004Shilpa Hakre, David M Brett-Major, Darrell E Singer, et al.
Science Translational Medicine|September 24, 2025
Afucosylation of anti-dengue IgG is associated with enhanced susceptibility to dengue virus infection postvaccinationUsama Ashraf, Saborni Chakraborty, Courtney Scallan, et al.
Vaccine|May 6, 2014
Designing the epitope flanking regions for optimal generation of CTL epitopesNicholas J Steers, Jeffrey R Currier, Ousman Jobe, et al.
AIDS (London, England)|December 3, 2019
Impact of analytical treatment interruption on the central nervous system in a simian-HIV modelDenise C Hsu, Decha Silsorn, Dutsadee Inthawong, et al.
NPJ Vaccines|December 22, 2017
Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvantOscar B Torres, Gary R Matyas, Mangala Rao, et al.
Mabs|August 25, 2020
Novel monoclonal antibodies to the SERINC5 HIV-1 restriction factor detect endogenous andvirion-associated SERINC5Sebastian Molnar, Lindsay Wieczorek, Michelle Zemil, et al.
Open Forum Infectious Diseases|October 30, 2019
Chikungunya and O'nyong-nyong Viruses in Uganda: Implications for DiagnosticsTamara L Clements, Cynthia A Rossi, Amanda K Irish, et al.
Pageof 39

Showing results (71-80 of 387) with videos related to

Sort By:
Pageof 39
Virology|April 26, 2008
Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cellsGustavo H Kijak, Luiz Mario Janini, Sodsai Tovanabutra, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 28, 2002
Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5Tarek Elbeik, W Gregory Alvord, Rapee Trichavaroj, et al.
Virology|April 25, 2008
Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different modelsBruce K Brown, Lindsay Wieczorek, Eric Sanders-Buell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2011
Medical encounter characteristics of HIV seroconverters in the US Army and Air Force, 2000–2004Shilpa Hakre, David M Brett-Major, Darrell E Singer, et al.
Science Translational Medicine|September 24, 2025
Afucosylation of anti-dengue IgG is associated with enhanced susceptibility to dengue virus infection postvaccinationUsama Ashraf, Saborni Chakraborty, Courtney Scallan, et al.
Vaccine|May 6, 2014
Designing the epitope flanking regions for optimal generation of CTL epitopesNicholas J Steers, Jeffrey R Currier, Ousman Jobe, et al.
AIDS (London, England)|December 3, 2019
Impact of analytical treatment interruption on the central nervous system in a simian-HIV modelDenise C Hsu, Decha Silsorn, Dutsadee Inthawong, et al.
NPJ Vaccines|December 22, 2017
Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvantOscar B Torres, Gary R Matyas, Mangala Rao, et al.
Mabs|August 25, 2020
Novel monoclonal antibodies to the SERINC5 HIV-1 restriction factor detect endogenous andvirion-associated SERINC5Sebastian Molnar, Lindsay Wieczorek, Michelle Zemil, et al.
Open Forum Infectious Diseases|October 30, 2019
Chikungunya and O'nyong-nyong Viruses in Uganda: Implications for DiagnosticsTamara L Clements, Cynthia A Rossi, Amanda K Irish, et al.
Pageof 39